The Longitudinal Epidemiologic Assessment of Diabetes Risk (LEADR): Unique 1.4 M patient Electronic Health Record cohort-Reference-Cited by-同舟云学术

The Longitudinal Epidemiologic Assessment of Diabetes Risk (LEADR): Unique 1.4 M patient Electronic Health Record cohort

Published:2020-12 Issue:4 Volume:8 Page:100458
ISSN:2213-0764
Container-title:Healthcare
language:en
Short-container-title:Healthcare

Author:

Fishbein Howard A.,Birch Rebecca Jeffries,Mathew Sunitha M.,Sawyer Holly L.,Pulver Gerald,Poling Jennifer,Kaelber David,Mardon Russell,Johnson Maurice C.,Pace Wilson,Umbel Keith D.,Zhang Xuanping,Siegel Karen R.,Imperatore Giuseppina,Shrestha Sundar,Proia Krista,Cheng Yiling,McKeever Bullard Kai,Gregg Edward W.,Rolka Deborah,Pavkov Meda E.

Funder

Centers for Disease Control and Prevention

Publisher

Elsevier BV

Subject

Health Policy

Reference31 articles.

1. Economic costs of diabetes in the U.S. in 2017;American Diabetes Association;Diabetes Care,2018

2. Prediabetes: a high-risk state for developing diabetes;Tabak;Lancet,2012

3. Rational use of electronic health records for diabetes population management;Eggleston;Curr Diabetes Rep,2014

4. Electronic health record phenotyping improves detection and screening of type 2 diabetes in the general United States population: a cross-sectional, unselected, retrospective study;Anderson;J Biomed Inf,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Examining incidence of diabetes in people with HIV: tracking the shift in traditional and HIV-related risk factors;AIDS;2024-02-05

2. Severe (level 3) hypoglycaemia occurrence in a real‐world cohort of adults with type 1 or 2 diabetes mellitus (iNPHORM, United States);Diabetes, Obesity and Metabolism;2023-09-13

3. How do we build a comprehensive Vein‐to‐Vein (V2V) database for conduct of observational studies in transfusion medicine? Demonstrated with the Recipient Epidemiology and Donor Evaluation Study‐IV‐Pediatric V2V database protocol;Transfusion;2023-08-19

4. Development and validation of a real‐world model to predict 1‐year Level 3 (severe) hypoglycaemia risk in adults with diabetes (the iNPHORM study, United States);Diabetes, Obesity and Metabolism;2023-07-06

5. Evaluation of available risk scores to predict multiple cardiovascular complications for patients with type 2 diabetes mellitus using electronic health records;Computer Methods and Programs in Biomedicine Update;2023